Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2017-02-27 / Eur. J. Pharmacol. 2017 May;802:85-92Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-12-01 / Urol Oncol 2016 12;34(12):538-547Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2016-10-10 / Stem Cell Res Ther 2016 10;7(1):149Immunotherapy for the Treatment of Urothelial Carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-07-25 / J Urol 2017 01;197(1):14-22Recent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial Carcinoma /von 2016-06-03 / BJU Int. 2016 10;118(4):506-14Emerging immunotherapies for glioblastoma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2016-06-01 / Expert Opin Emerg Drugs 2016 Jun;21(2):133-45Oncolytic virotherapy for urological cancers
/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2016-05-24 / Nat Rev Urol 2016 Jun;13(6):334-52Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
/in International Publications, Newcastle Disease Virus /von 2016-05-12 / J. Virol. 2016 06;90(11):5343-5352Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy
/in International Publications, Newcastle Disease Virus /von 2016-05-07 / Virus Res. 2016 08;221:23-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de